The GCC Catheter Market Will Continue to Grow in 2024.

Projected Growth of the GCC Catheter Market

The Gulf Cooperation Council (GCC) catheter market is expected to reach a value of 579.83 million USD by 2024 and is projected to grow to 1.28 billion USD by 2033. During this period, a compound annual growth rate (CAGR) of 9.21% is anticipated. This growth is supported by the increasing prevalence of chronic diseases, the rise of surgical procedures, and the widespread development of advanced healthcare infrastructure in the region. Additionally, the aging population and the demand for minimally invasive treatments further strengthen market expansion.

Main sectors such as vascular, microcatheters, and intermittent catheters are experiencing significant growth. Key players in the market include Abbott Laboratories, Edwards Lifesciences, and Medtronic. Saudi Arabia's Vision 2030 initiative and healthcare reforms in the United Arab Emirates are also significant factors contributing to market growth.

A Market with Rising Chronic Diseases and an Aging Population

The burden of chronic diseases in GCC countries is growing with the increase of conditions such as cardiovascular diseases, diabetes, and kidney diseases. The rapidly aging population is driving demand due to the rising incidence of conditions requiring catheterization. The World Health Organization emphasizes that non-communicable diseases are on the rise in the Middle East, affecting GCC countries as well. Demographic changes necessitate increased use of catheters in diagnostic and therapeutic processes.

Investments by governments to modernize hospitals and the adoption of high-tech medical devices by private healthcare companies are driving the increase in catheterization procedures. As a result, catheters play a critical role in both acute and long-term patient management in the region.

Supporting Developments and Challenges in the Market

The high cost of advanced medical device technologies may pose a barrier to widespread adoption in the GCC. It is believed that not every healthcare facility can afford the latest catheterization equipment. Additionally, varying regulatory standards and approval mechanisms across countries are significant factors influencing market growth. This complex regulatory environment can delay the market entry of products.

The GCC cardiovascular catheter market is rapidly growing due to the rising rates of heart disease and the increasing prevalence of interventional cardiology procedures. Furthermore, microcatheters provide high precision in neurovascular and peripheral vascular interventions. Intermittent catheters enhance patient comfort and offer home care solutions, increasing demand. Short peripheral intravenous catheters are frequently used in emergencies, supporting growth in this market segment.